Skip to main content

Norway

18
Jan 2023

2023 Pathology Activity Codes (APAT) system and reimbursement tariffs released in Norway

In January 2023, the updated Pathology Activity Codes (APAT) of the Norwegian Pathology Code system (NORPAT) came into force. Since 2022, APAT codes have been included in the new reimbursement scheme by Helfo (the Norwegian Health Economics Administration) for outpatient pathology services. Five new classified sample materials for cytology and 22 new additional codes for the method of testing were added to the scheme in 2023.
29
Dec 2022

2023 Norwegian DRG system released

In December 2022, the Norwegian Directorate of Health published the final version of the DRG system (Innsatsstyrt finansiering, ISF) for 2023. Eight new DRGs concerning endocrinology, surgical procedures, infection diseases, genetics, and the general area will be added in 2023.
13
Dec 2022

Regular update of the Norwegian Laboratory Code System released

On November 23, 2022, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system and associated tariffs for state and private laboratories to be implemented no later than January 1, 2023. Eighty-six new codes were added, 207 codes were changed, and 27 codes were terminated.
02
Nov 2022

Call for input regarding hand-held ECG (such as KardiaMobile) for the New Methods framework in Norway

In October 2022, Ordering Forum for New Methods framework in Norway invited interested parties regarding hand-held electrocardiogram (ECG) devices connected to an app for diagnosing atrial fibrillation in adults (e.g., KardiaMobile). Information shall be submitted no later than November 29, 2022. Ordering Forum will be held on December 12, 2022, to decide whether the method will undergo evaluation at the national level.
28
Oct 2022

The “New Method” is developing prioritization criteria for the evaluation of medical technologies and procedures in Norway

The “New Method” is currently developing criteria for which methods other than drugs shall be prioritized for assessment within the framework at the national or local levels. On October 04, 2022, the development status was reported to the Ministry of Health and Care with the proposal on how the existing criteria could be used together with the criteria of the regulatory work in HTA.
21
Oct 2022

The 2023 procedure coding system (NCMP-NCSP-NCRP) released in Norway

In October 2022, the Norwegian Directorate of e-Health released the procedure coding system for 2023. A total of 54 new codes will be introduced from January 2023: 19 surgical procedure codes (NCSP) concerning neurology and neurosurgery, neurovascular, cardiovascular, eHealth, diagnostic imaging, pulmonary and airwaves, radiotherapy, nephrology, peripheral vascular, and surgical procedures, 17 radiology procedure codes (NCRP), and 18 medical procedure codes (NCMP).
13
Oct 2022

Regular update of the Norwegian Laboratory Code System released

On September 23, 2022, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system and associated tariffs for state and private laboratories to be implemented no later than November 01, 2022. Twenty-three new codes were added, six codes were changed, and 126 codes were terminated.
21
Sep 2022

Call for input regarding electric field therapy (Optune) for the New Methods framework

In September 2022, Ordering Forum for New Methods has invited interested parties regarding electric field therapy (Optune, Tumor Treating Fields) alone or in combination with drugs for certain groups of glioblastoma patients, based on genome sequencing and biomarkers (indication II). Information should be submitted before November 8, 2022. Ordering Forum will be held on November 21, 2022, to decide whether the method will undergo evaluation at the national level.
15
Sep 2022

National screening program for colorectal cancer launched in Norway

On August 25, 2022, the Norwegian Directorate of Health announced the launch of the National screening program for colorectal cancer (Bowel screening program - Tarmscreeningprogrammet). All 55-year-old men and women will be included in the program and offered a test to identify invisible blood in the stool (fecal immunochemical test, FIT) every two years until the age of 65. Colonoscopy will be offered in case of positive FIT.